Concepedia

Publication | Closed Access

A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis

DOI

77

Citations

43

References

2005

Year

Dennis Bourdette, E.V.J. Edmonds, Cassandra Smith, James D. Bowen, Charles R.G. Guttmann, Zs. Nagy, Jack H. Simon, Ruth H. Whitham, Jesús Lovera, Vijayshree Yadav,
Multiple Sclerosis Journal

Abstract

The trivalent TCR peptide in IFA vaccine represents a significant improvement in immunogenicity over previous TCR peptide vaccines and warrants investigation of its ability to treat MS.

References

YearCitations

Page 1